- Home
- BCRX vs MFIC Comparison
BCRX vs MFIC Comparison
Compare BCRX & MFIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- MFIC
- Stock Information
- Founded
- BCRX 1986
- MFIC 2004
- Country
- BCRX United States
- MFIC United States
- Employees
- BCRX N/A
- MFIC N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- MFIC Finance/Investors Services
- Sector
- BCRX Health Care
- MFIC Finance
- Exchange
- BCRX Nasdaq
- MFIC Nasdaq
- Market Cap
- BCRX 1.7B
- MFIC 1.4B
- IPO Year
- BCRX 1994
- MFIC 2004
- Fundamental
- Price
- BCRX $7.40
- MFIC $11.76
- Analyst Decision
- BCRX Buy
- MFIC Hold
- Analyst Count
- BCRX 6
- MFIC 5
- Target Price
- BCRX $15.67
- MFIC $14.13
- AVG Volume (30 Days)
- BCRX 3.2M
- MFIC 665.5K
- Earning Date
- BCRX 05-05-2025
- MFIC 05-12-2025
- Dividend Yield
- BCRX N/A
- MFIC 12.95%
- EPS Growth
- BCRX N/A
- MFIC N/A
- EPS
- BCRX N/A
- MFIC 1.27
- Revenue
- BCRX $450,712,000.00
- MFIC $301,782,000.00
- Revenue This Year
- BCRX $27.64
- MFIC $15.35
- Revenue Next Year
- BCRX $13.42
- MFIC $2.93
- P/E Ratio
- BCRX N/A
- MFIC $9.28
- Revenue Growth
- BCRX 36.00
- MFIC 9.13
- 52 Week Low
- BCRX $4.03
- MFIC $10.18
- 52 Week High
- BCRX $9.50
- MFIC $16.36
- Technical
- Relative Strength Index (RSI)
- BCRX 50.46
- MFIC 44.86
- Support Level
- BCRX $6.02
- MFIC $10.70
- Resistance Level
- BCRX $7.41
- MFIC $11.54
- Average True Range (ATR)
- BCRX 0.44
- MFIC 0.55
- MACD
- BCRX 0.06
- MFIC 0.01
- Stochastic Oscillator
- BCRX 81.66
- MFIC 54.86
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About MFIC MidCap Financial Investment Corporation
MidCap Financial Investment Corp is an externally managed, publicly traded, closed-end, diversified management investment company. Its investment objective is to generate current income and, to a lesser extent, long-term capital appreciation. It predominantly invests in directly originated and privately negotiated first lien senior secured loans to privately held U.S. middle-market companies, and in other types of securities including, first lien unitranche, second lien senior secured, unsecured, subordinated, and mezzanine loans, and equities in both private and public middle market companies.